# Stem Cells Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Biotechnology](https://www.ihealthcareanalyst.com/reports/biotechnology/amp/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Stem Cells Market by Product (Adult/Somatic Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Rat Neural Stem Cells, Other Stem Cells); by Technology (Cryopreservation, Stem Cells Isolation, Stem Cells Culture, In Vitro Fertilization); by Application (Cardiovascular, Diabetes, Hematology, Incontinence, Liver Disorders, Myocardial infarction, Neurology, Oncology, Orthopedics, Spinal cord injuries, Wound Care, Others)and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Stem cell-based therapies, also known as cell replacement therapies or regenerative medicine, provide the means to cure a host of diseases and disorders. There are various types of stem cells (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products in different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics diseases and disorders).

Bone marrow derived stem cells have been used for various therapeutic purposes such as such as thalassemia, aplastic anemia, and sickle cell anemia, and leukemia. Umbilical cord or cord blood is considered a rich source of stem cells which are derived mesenchymal stem cells that are used in regenerative therapies for various medical conditions including diabetes, Alzheimer’s disease, soft tissue repair, etc.

The stem cells market report estimates the market size ($million 2023 to 2033) and segmented based on different stem cell technologies such as stem cells isolation, culture, cryopreservation, IVF, etc., stem cell types (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products and different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics) available in the global market and also forecast (CAGR%, 2025 to 2033).

The global stem cells market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global stem cells market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global stem cells market and included in this report are Advanced Cell Technology, Inc., Aastrom Biosciences, Inc., BetaStem Therapeutics, Inc., Cardio3 Biosciences, Cellular Dynamics International (CDI), Cynata Therapeutics, Inc., Cytori Therapeutics, Inc., Dendreon Corp., Gamida Cell Ltd., Genea Biocell Pty. Ltd., Lonza Group AG, MaxCyte, Medipost, Mesoblast Ltd., Osiris Therapeutics, Inc., Organovo, Pluristem Therapeutics, Inc., Regeneus Ltd., STEMCELL Technologies, Inc., TerumoBCT, Thermo Fisher Scientific and VIACYTE, Inc.

**DATA INCLUDED:** Stem Cells Market Size, Stem Cells Market Share, Stem Cells Market Growth Rates, Stem Cells Market Trends, and Stem Cells Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Stem Cells Market by Product (Adult/Somatic Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Rat Neural Stem Cells, Other Stem Cells); by Technology (Cryopreservation, Stem Cells Isolation, Stem Cells Culture, In Vitro Fertilization); by Application (Cardiovascular, Diabetes, Hematology, Incontinence, Liver Disorders, Myocardial infarction, Neurology, Oncology, Orthopedics, Spinal cord injuries, Wound Care, Others)and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents BT](#tab-table-of-contents-bt)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-pages)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer_ _Market Segments and Companies Tab_\]
    *   Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    *   Source Type
    *   Reagents and Consumables Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer_ _Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Stem Cells Market**

1\. **Product/Stem Cell Type**  
1.1. Adult/Somatic Stem Cells  
1.2. Human Embryonic Stem Cells  
1.3. Induced Pluripotent Stem Cells  
1.4. Rat Neural Stem Cells  
1.5. Other Stem Cells

2\. **Technology**  
2.1. Cryopreservation  
2.2. Culture  
2.3. Expansion and Sub-culture  
2.4. _In Vitro_ Fertilization (IVF)  
2.5. Isolation

3\. **Application**  
3.1. Cardiovascular  
3.2. Diabetes  
3.3. Hematology  
3.4. Incontinence  
3.5. Liver disorders  
3.6. Myocardial infarction  
3.7. Neurology  
3.8. Oncology  
3.9. Orthopedics  
3.10. Spinal cord injuries  
3.11. Wound care  
3.12. Others

4\. **Company Profiles**  
4.1. Advanced Cell Technology  
4.2. Angel Biotechnology  
4.3. Bioheart  
4.4. Biotime Inc.  
4.5. Brainstorm Cell Therapeutics  
4.6. California Stem Cell Inc.  
4.7. Celgene Corporation Inc.  
4.8. Cellartis AB  
4.9. Cellular Engineering Technologies  
4.10. Cytori Therapeutics Inc.  
4.11. Osiris Therapeutics  
4.12. Stem Cell Technologies Inc.

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#cdbeaca1a8be8da4a5a8aca1b9a5aeacbfa8aca3aca1b4beb9e3aea2a0)

[](# "Scroll back to top")

Search for: